10
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, Characterization and Cytotoxicity of New Complexes of Cobalt(III), Nickel(II) and Copper(II) with Quinoxaline-2-carboxaldehyde Thiosemicarbazone

&
Pages 1773-1788 | Received 01 Mar 1993, Accepted 23 Aug 1994, Published online: 22 Aug 2006
 

Abstract

New quinoxaline-2-carboxaldehyde thiosemicarbazone (H-QTSC) complexes of cobalt(III), nickel(II) and copper(II) have been prepared and characterized on the basis of elemental analyses, molar conductance, magnetic susceptibility, and electronic and infrared spectral data. Analytical and molar conductance data suggest that the complexes have the formulae [Co(QTSC)2IX, [Ni(H-QTSC)2(OAc)X] and [Cu(QTSC) (OAc) (H2O)]2 (where X = Cl or Br and OAc = acetate). The magnetic and spectral data suggest a distorted octahedral geometry for the complexes. The copper complex appears to be dimeric with bridging acetate groups. The ligand acts as a uninegative tridentate NNS donor in the cobalt and copper complexes, while it acts as a neutral bidentate NS donor in the nickel complexes. The cytotoxicity of the cobalt(III) complexes were determined in vitro as well as in tissue culture. The chloro complex was found to have greater cytotoxic activity than the bromo complex.

Referee I: G. Dyer

Referee II: A. Pidcock

Notes

Referee I: G. Dyer

Referee II: A. Pidcock

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.